In the late research/early development stage of a biologic, it is often necessary to produce a larger quantity of a protein than a company is capable of producing internally. At this stage, the availability of the purified protein may govern its continued development. The protein needs to be produced with a minimal amount of waste; i.e., with a minimal amount of personnel and expense, in the shortest amount of time possible…
JUST PUBLISHED: "Standardized and GMP-Ready, Closed-System Processing of Expanded Adipose-Derived Stem Cells Using the Gibco CTS
Rotea System Across 2D and 3D Bioreactor Expansions." Click on the OPEN ACCESS ARTICLES tab below.
